跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVA APIXABAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVA APIXABAN
Authorized
STANDARD
RIVA APIXABAN
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
272ad72ad35c1262
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
272ad72ad35c1262
Drug Approval Canada Name
RIVA APIXABAN
Product Name
RIVA APIXABAN
Status
Marketed
Status Date
2024-06-04
Original Market Date
2022-10-06
Din
02525526
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
20:12.04.14
Atc Original
B01AF02 APIXABAN
Atc Name
b 01 af 02
Aig Number
0153051002
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
APIXABAN
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
272ad72ad35c1262
Type
Standard
Back to Health Canada Approvals